• The New Normal for Clinical Trials

    Jan 31, 2011, 02:20 by Michael Croft

    Jan 31 | eCliniqua | An assortment of emerging clinical trial technologies over the past decade are providing creative ways for pharmaceutical companies and clinical research organizations (CROs) to boost the quality, pace, and efficiency of their drug development programs. The promise is sporadically realized by companies that selectively and appropriately apply these tools and use timely and visible performance metrics as the basis for relationship-building with clinical investigators. Working recipes are not often diligently followed, however. Thus clinical trials performance, in the main, remains dreadful.

    Full story
  • Government to Fund Drug Research

    Jan 25, 2011, 01:30 by Michael Croft

    Jan 25 | New York Times | The government's new drug development center, the National Center for Advancing Translational Sciences, isn't intended to be comptetitive with the private sector, says NIH director Francis Collins. The center is slated to open in October and will be one of the 27 centers and institutes under the National Institutes of Health.

    Full story
  • Cetero Hires Former Schering-Plough Bioanalytical Director

    Jan 20, 2011, 04:50 by Michael Croft

    Jan 20 | News Brief | Cetero Research, an early-stage contract research organization, has appointed Roger Hayes as president, bioanalytical operations. For the past 10 years, Hayes has served as director of bioanalytical at Schering-Plough Research Institute. 

    Full story
  • Past Clinical Trials Not Cited

    Jan 18, 2011, 08:45 by Michael Croft

    Jan 18 | New York Times |  Johns Hopkins researchers have found that published papers on clinical trials rarely cite previous works on the same topic.

    Full story
  • Partnering with Pharma: A New CRO Approach

    Jan 18, 2011, 08:40 by Michael Croft

    Jan 18 | eCliniqua | Mike Wilkinson, CIO and executive vice president at PPD, has a message for pharma: “We’re in this together as partners; we’re not a vendor anymore. I think we need to move away from that kind of transactional approach where all they’re looking for is to have a vendor and buy a service. That’s not going to work in this environment.”

    Full story
  • Merck, Parexel Sign Generics Deal

    Jan 13, 2011, 03:40 by Michael Croft

    Jan 13 | Boston Business Journal | Parexel and Merck have signed a deal to help the pharma develop generic versions of biologics.

    Full story
  • Portal Partnering: Connecting Pharma and CROs

    Jan 10, 2011, 06:00 by Michael Croft

    Jan 10 | Comment |  The contract research market grew 13% in 2009, reaching $23.5 billion, according to the Contract Research Annual Review 2010 report. But as these partnerships with contract research organizations (CRO) become more common, it will become essential to establish collaborative communications with their partners and leverage workflows to help encourage communication and improve the efficiency of the working relationship. A partner portal, connecting the sponsor with the CRO, is an effective platform to achieve these goals.

    Full story
  • First Candidate from Nanoengineering Platform

    Jan 10, 2011, 05:40 by Michael Croft

    Jan 10 | News Brief | BIND Biosciences has started the Phase 1 trial for the first candidate from its broad proprietary Medicinal Nanoengineering platform.

    Full story
  • Drug Approvals Down in 2010

    Jan 5, 2011, 00:25 by Michael Croft

    Jan 5 | Wall Street Journal | The FDA approved about 21 drugs in 2010, a relatively modest figure that shows the pharmaceutical industry hasn't yet escaped its drought in recent years.

    Full story
  • DIA Launches Regulator Affairs Certificate Program

    Jan 5, 2011, 00:15 by Michael Croft

    Jan 5 | News Brief | DIA has announced a regulatory affairs certificate program to provide comprehensive training on current regulations and their practical application to the development and commercialization of pharmaceutical, biotechnology, medical device, and related health care products.

    Full story
  • EMRs Have Mixed Effects on Productivity

    Dec 27, 2010, 00:00 by Michael Croft

    Dec 27 | UC Davis | A UC Davis study has found that electronic medical records may not be the "silver bullet" of health care reform that some hoped. The study measured the impact of electronic medical record-keeping on doctors' productivity.

    Full story
  • Health-IT Trends for 2011

    Dec 22, 2010, 00:00 by Michael Croft

    Dec 22 | Healthcare IT News | PwC has released six healthcare trends for 2011 based on a survey of 1,000 Americans including record spending on health-IT, big changes in benefit plan design and pricing, and further merger and acquisition activity.

    Full story
  • Evado to Launch Chinese Version of Clinical Trials Software

    Dec 20, 2010, 11:20 by Michael Croft
    Dec 19 | News Brief | Evado has entered a partnership with Taiwan’s clinical research organization, Fuga Biotechnology which will have exclusive distribution rights in Taiwan. Evado said it would develop a Chinese version of the Evado clinical trials software system with Fuga in 2011.

     

    Full story
  • TechTeam Global Acquired by Stefanini

    Dec 20, 2010, 11:15 by Michael Croft

    Dec 17 | News Brief | TechTeam Global has been acquired by Stefanini IT Solutions Group, resulting in a merger of the two companies to form a new subsidiary, Stefanini TechTeam.

    Full story
  • Reducing the Burden of Clinical Safety Reporting

    Dec 20, 2010, 10:25 by Michael Croft
    Dec 21 | Commentary | Serious adverse event (SAE) reporting during clinical trials is a time-consuming, costly, and often manual task for investigational sites, and adds significant burden to research sponsors’ data management teams. EDC prevalence at investigational sites provides opportunity to automate and simplify SAE reporting.
    Full story
  • Charles River Plans Closure of Two Facilities

    Dec 16, 2010, 02:05 by Michael Croft

    Dec 16 | Mass High Tech | Charles River Laboratories plans seek "strategic alternatives" for two facilities: a Phase I research clinic in the U.S. and a pre-clinical research facility in China.

    Full story
  • Medtronic Announces Diabetes Decision Support

    Dec 15, 2010, 03:45 by Michael Croft

    Dec 15 | News Brief | Medtronic has announced the Food and Drug Administration (FDA) approval and the market launch of CareLink Pro 3.0 Therapy Management Software, the first software program to offer advanced decision support to health care professionals managing diabetes.

    Full story
  • Octagon, ScenPro Support FDA Data Conversion Project

    Nov 30, 2010, 00:00 by Michael Croft
    Nov 30 | News Brief | Octagon and ScenPro have partnered to support the FDA's large-scale legacy data conversation project. The project addresses legacy data that resides in numerous different formats at FDA that must be converted into standard structures.

     

    Full story
  • Taming the Beast

    Nov 15, 2010, 05:31 by Michael Croft

    Nov 15 | eCliniqua | Copernicus Group made a fairly weighty donation to a local North Carolina school last month: four boxes of paperclips and binder clips all formerly used to wrangle the “paper-moving beast” that was Copernicus’ clinical trial review process. The independent institutional review board (IRB) doesn’t need them anymore. They’ve gone completely paperless.

    Full story
  • Novel IT Platform Helps Novartis Gain Control of Clinical Imaging Data

    Nov 15, 2010, 05:00 by Michael Croft

    Nov 16 | eCliniqua | Researchers at Novartis in Basel have developed a powerful new electronic data capture (EDC) hub for clinical data that has allowed its investigators to control data across multiple trials as never before, according to David Tuch, head of clinical imaging at the Novartis Institute for Biomedical Research, Switzerland. “This is a game changer for managing clinical trials at Novartis.”

    Full story